{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T02:40:18Z","timestamp":1740969618593,"version":"3.38.0"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1650,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1600-0463.2011.02729.x","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T14:44:06Z","timestamp":1298731446000},"page":"356-363","source":"Crossref","is-referenced-by-count":4,"title":["Cefpodoxime 10\u2003\u03bcg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes"],"prefix":"10.1111","volume":"119","author":[{"given":"ATHENA","family":"LIMNIOS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHN","family":"TAPSALL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JENNY","family":"KAHLMETER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIFFANY","family":"HOGAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SANGHAMITRA","family":"RAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANNE","family":"LAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAGNUS","family":"UNEMO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,2,24]]},"reference":[{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.09.63","article-title":"Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae","volume":"7","author":"Tapsall","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/sti.2008.035337","article-title":"Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci","volume":"85","author":"Tapsall","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656560902731993","article-title":"The use of cephalosporins for gonorrhea: the impending problem of resistance","volume":"10","author":"Barry","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/AAC.01604-06","article-title":"Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA","volume":"51","author":"Lindberg","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1128\/AAC.00626-06","article-title":"Amino acid substitutions of mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae","volume":"50","author":"Takahata","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.00304-09","article-title":"Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae","volume":"53","author":"Zhao","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1021\/bi101167x","article-title":"Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations","volume":"49","author":"Tomberg","year":"2010","journal-title":"Biochemistry"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/sti.2010.045377","article-title":"Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden","volume":"86","author":"Golparian","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/jac\/dkq377","article-title":"Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains","volume":"65","author":"Whiley","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.00198-08","article-title":"Ceftibuten resistance and treatment failure in gonococcal infection","volume":"52","author":"Lo","year":"2008","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment for gonorrhea","volume":"13","author":"Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB12|cit12","doi-asserted-by":"crossref","unstructured":"Unemo M Golparian D Syversen G Vestrheim DF Moi H Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010 http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19721","DOI":"10.2807\/ese.15.47.19721-en"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/AAC.00306-07","article-title":"Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone","volume":"51","author":"Whiley","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-008-0610-7","article-title":"Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone","volume":"14","author":"Osaka","year":"2008","journal-title":"J Infect Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkp505","article-title":"Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone","volume":"65","author":"Lee","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0950268809990148","article-title":"Experience with an external quality assurance scheme for antimicrobial susceptibility testing of Neisseria gonorrhoeae in India, 2001-2007","volume":"138","author":"Bala","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jac\/dkp098","article-title":"Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes","volume":"63","author":"Unemo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB18|cit18","unstructured":"WHO GASP Document, \u201cRationale and applications for the current (2008) WHO panel of Neisseria gonorrhoeae for antimicrobial resistance surveillance for public health purposes, and instructions for their use\u201d 2008"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB19|cit19","first-page":"175","volume-title":"Antimicrobial Susceptibility Testing: Methods and Practices with an Australian Perspective","author":"Tapsall","year":"2004"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB20|cit20","unstructured":"The CDS Antibiotic Susceptibility Test http:\/\/web.med.unsw.edu.au\/cdstest"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/00313029500169492","article-title":"The sensitivity of 173 Sydney isolates of Neisseria gonorrhoeae to cefpodoxime and other antibiotics used to treat gonorrhoea","volume":"27","author":"Tapsall","year":"1995","journal-title":"Pathology"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/00313020701444515","article-title":"Use of a novel screening PCR indicates presence of Neisseria gonorrhoeae with a mosaic penA gene sequence in Australia","volume":"39","author":"Whiley","year":"2007","journal-title":"Pathology"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1600-0463.2008.01062.x","article-title":"Real-time PCR and subsequent pyrosequencing for screening of penA mosaic alleles and prediction of reduced susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae","volume":"116","author":"Unemo","year":"2008","journal-title":"APMIS"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/AAC.00406-09","article-title":"Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California","volume":"53","author":"Pandori","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1600-0463.2011.02729.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/JCM.01800-07","article-title":"Rapid detection of the mosaic structure of the Neisseria gonorrhoeae penA gene, which is associated with decreased susceptibilities to oral cephalosporins","volume":"46","author":"Ochiai","year":"2008","journal-title":"J Clin Microbiol"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0463.2011.02729.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0463.2011.02729.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T01:40:33Z","timestamp":1740966033000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0463.2011.02729.x"}},"subtitle":["CEFPODOXIME DISC DETECTING GONOCOCCI WITH DECREASED CEPHALOSPORIN SUSCEPTIBILITY"],"short-title":[],"issued":{"date-parts":[[2011,2,24]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0463.2011.02729.x","relation":{},"ISSN":["0903-4641"],"issn-type":[{"type":"print","value":"0903-4641"}],"subject":[],"published":{"date-parts":[[2011,2,24]]}}}